Baidu-backed drug discovery start-up Biomap challenges Google’s AlphaFold

Baidu-backed drug discovery start-up Biomap challenges Google’s AlphaFold

Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government, says it has surpassed Alphabet subsidiary AlphaFold in commercialising artificial intelligence foundation models for drug discovery. Multinational pharmaceutical companies were seeing a “reverse” in the technological gap between Biomap and AlphaFold, Wei Liu, co-founder and CEO of…

Read More
Chinese start-up breaks US monopoly in 3D imaging of biomolecules, aims for IPO in 2027

Chinese start-up breaks US monopoly in 3D imaging of biomolecules, aims for IPO in 2027

Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen…

Read More